BioNexus Gene Lab Corp.
BGLC
$5.30
-$0.12-2.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.06M | 3.60M | 4.38M | 4.14M | 5.41M |
| Total Receivables | 2.10M | 1.77M | 1.66M | 1.51M | 1.40M |
| Inventory | 1.22M | 1.18M | 1.39M | 1.39M | 1.03M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 6.38M | 6.54M | 7.43M | 7.04M | 7.84M |
|
|
|||||
| Total Current Assets | 6.38M | 6.54M | 7.43M | 7.04M | 7.84M |
| Net Property, Plant & Equipment | 1.79M | 1.72M | 1.74M | 1.96M | 1.59M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.42M | 9.48M | 10.43M | 11.00M | 11.14M |
|
|
|||||
| Total Accounts Payable | 1.37M | 1.18M | 1.50M | 1.03M | 954.80K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 15.80K | 16.30K | 17.20K | 18.60K | 215.50K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 55.80K | 52.20K | 50.80K | 48.20K | 53.20K |
| Total Finance Division Other Current Liabilities | 318.70K | 309.20K | 380.00K | 315.00K | 175.80K |
| Total Other Current Liabilities | 318.70K | 309.20K | 380.00K | 315.00K | 175.80K |
| Total Current Liabilities | 1.76M | 1.56M | 1.95M | 1.41M | 1.40M |
|
|
|||||
| Total Current Liabilities | 1.76M | 1.56M | 1.95M | 1.41M | 1.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 15.80K | 16.30K | 17.20K | 18.60K | 215.50K |
| Capital Leases | 141.30K | 147.90K | 159.70K | 178.40K | 182.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 13.60K | 11.90K |
| Total Liabilities | 1.90M | 1.71M | 2.11M | 1.61M | 1.59M |
|
|
|||||
| Common Stock & APIC | 17.33M | 17.33M | 17.33M | 17.33M | 17.19M |
| Retained Earnings | -4.68M | -4.07M | -3.44M | -3.09M | -1.75M |
| Treasury Stock & Other | -5.13M | -5.49M | -5.57M | -4.85M | -5.90M |
| Total Common Equity | 7.52M | 7.77M | 8.32M | 9.39M | 9.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.52M | 7.77M | 8.32M | 9.39M | 9.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.52M | 7.77M | 8.32M | 9.39M | 9.55M |
|
|
|||||